Mordor Intelligence has published a new report on the next-generation sequencing market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Next-Generation Sequencing Market Overview
According to Mordor Intelligence, the next-generation sequencing market size is projected to reach USD 11.81 billion in 2026 and further expand to USD 22.43 billion by 2031, growing at a CAGR of 13.69% during the forecast period. This growth reflects the increasing role of genomic technologies across healthcare, research, and public health systems. The market growth is supported by wider adoption in clinical diagnostics, increasing demand for faster sequencing workflows, and government-backed genomic programs.
The next-generation sequencing industry is seeing steady demand from precision medicine initiatives, where sequencing plays a central role in identifying disease patterns and guiding treatment decisions. Healthcare systems are incorporating sequencing into routine diagnostics, especially in oncology and rare disease detection. At the same time, academic and research institutions continue to invest in sequencing technologies to support genetic studies and large-scale genomic databases.
Next-Generation Sequencing Market Trends
Rising Demand for Precision Medicine
The growing use of sequencing in personalized healthcare is one of the key next-generation sequencing market trends. Hospitals and healthcare providers are increasingly relying on genomic data to tailor treatments, especially in cancer care. Companion diagnostics are becoming a standard part of treatment planning, supporting better patient outcomes and improving the market growth.
Shift Toward Open-Chemistry Platforms
A notable shift in the next-generation sequencing industry is the move away from closed systems toward open-chemistry platforms. These platforms allow users to choose consumables independently from hardware, offering flexibility and cost control. This trend is influencing purchasing decisions and reducing dependence on proprietary ecosystems, which is gradually impacting the market share of established companies.
Supply Chain and Regulatory Considerations
Supply chain challenges related to semiconductor components and reagent materials are becoming more visible. Governments now view these dependencies as strategic concerns, leading to efforts to localize production. At the same time, regulatory clarity is improving, making it easier for new entrants to enter the next-generation sequencing market. These factors are shaping the market forecast and influencing long-term investment strategies.
Sustainability and Carbon Accountability
Sustainability is gaining attention in procurement decisions. Public-funded biobanks and research programs are evaluating vendors based on environmental impact, including energy usage and carbon footprint. This trend is pushing companies in the next-generation sequencing industry to provide transparent reporting and adopt eco-friendly practices, adding a new dimension to market trends.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/global-next-generation-sequencing-ngs-market-industry?utm_source=emailwire
Next-Generation Sequencing Market Segmentation
By Type of Sequencing
- Whole Genome Sequencing
- Targeted Resequencing
- Whole Exome Sequencing
- RNA Sequencing
- ChIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
By Product Type
- Instruments
- Reagents and Consumables
- Services
By Application
- Drug Discovery and Personalized Medicine
- Genetic Screening
- Diagnostics
- Agriculture and Animal Research
- Other Applications including epigenomics, metagenomics, and transcriptomics
By End User
- Hospitals and Healthcare Institutions
- Academic Institutions
- Pharmaceutical and Biotechnology Companies
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
Explore Our Full Library of Healthcare Research Report:
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire
Next-Generation Sequencing Market Key Players
The competitive landscape of the next-generation sequencing market is characterized by a mix of established leaders and emerging challengers. While leading companies maintain a strong presence, new entrants are gaining attention with cost-effective and flexible solutions.
Key Players in the Next-Generation Sequencing Industry
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Oxford Nanopore Technologies Plc
Explore more insights on next-generation sequencing competitive landscape: https://www.mordorintelligence.com/industry-reports/global-next-generation-sequencing-ngs-market-industry/companies?utm_source=emailwire
Conclusion
The market is set for steady expansion as demand grows across healthcare, research, and public health applications. The integration of sequencing into routine clinical workflows and the rise of personalized medicine are key contributors to the next-generation sequencing market growth.
At the same time, the industry is undergoing changes in how technologies are developed, purchased, and used. The move toward open systems, focus on sustainability, and increasing regulatory clarity are shaping the market trends. These factors are expected to influence competition and drive innovation within the next-generation sequencing industry.
Get detailed insights on the next-generation sequencing market:
Industry Related Reports
Contrast Media Injectors Market:
The Contrast Media Injectors Market is experiencing growth driven by increasing demand for advanced diagnostic imaging procedures and rising prevalence of chronic diseases. Technological advancements in injector systems and growing adoption in radiology and interventional cardiology are further supporting market expansion.
Get more insights: https://www.mordorintelligence.com/industry-reports/contrast-media-injectors-market?utm_source=emailwire
Microfluidics Market size:
The Microfluidics Market size is projected to grow from USD 24.15 billion in 2025 to USD 46.13 billion by 2031, registering a CAGR of 11.39%. Growth is driven by increasing applications in healthcare diagnostics, drug delivery, and rising demand for lab-on-a-chip technologies.
Get more insights: https://www.mordorintelligence.com/industry-reports/microfluidics-market?utm_source=emailwire
Mass Spectrometry Market share:
The Mass Spectrometry Market is expected to expand from USD 7.16 billion in 2025 to USD 10.56 billion by 2031, growing at a CAGR of 6.68%. Rising use in pharmaceutical research, environmental testing, and advancements in analytical technologies are key growth factors.
Get more insights: https://www.mordorintelligence.com/industry-reports/mass-spectrometry?utm_source=emailwire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
